Dr. Tzvi Nussbaum, MD

Dr. Nussbaum practices at Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health.

Dr. Nussbaum's NPI, 1205938255, was assigned on September 1, 2006. Dr. Nussbaum graduated from Chicago College of Medicine and Surgery in 1997. Dr. Nussbaum holds North Carolina license 2005-01306.

Dr. Nussbaum's primary practice is Atrium Health Carolinas Medical Center, at 1000 Blythe Blvd, Charlotte, NC 28203 in Mecklenburg County. The practice phone is (704) 355-2000.

Dr. Nussbaum's primary practice is Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health. Dr. Nussbaum is also affiliated with Atrium Health Pineville. The medical group on file is Atrium Health Cleveland Imaging. Dmand AI also links Dr. Nussbaum to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nussbaum practices, 7 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Nussbaum's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Nussbaum is licensed in North Carolina.

CMS data shows 538 Medicare services from Dr. Nussbaum across 16 procedure codes in 2024, for 359 Medicare patients. Medicare paid $52,211 for them.

CMS counts 359 Medicare patients who saw Dr. Nussbaum in 2024. The largest group is 75 to 84, with 148 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nussbaum's median patient age at 72, with 46% women.

In 2024, Dr. Nussbaum wrote 220 Medicare Part D claims for 68 patients. 61% of them were for generic drugs. CMS names the drug for 174 of them, across 5 drugs with 11 or more claims each, at $74,341 in total drug cost. In 2023, CMS named 150 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Nussbaum for performance year 2024, reported through an alternative payment model (APM). Dr. Nussbaum accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nussbaum as offering telehealth. CMS counts 23 procedures of leg revascularization (restoring blood flow) by Dr. Nussbaum, more than 83% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Nussbaum, published from 2018 to 2023. 2018 was the busiest year, with 3. The most frequent topics are Blood Vessel Prosthesis Implantation, Endovascular Procedures and Aortic Dissection. Dr. Nussbaum has published most often in J Vasc Surg. Dr. Nussbaum's most frequent co-authors are Frank R. Arko, MD, John Richards Frederick, MD and Jeko Metodiev Madjarov, MD.

CMS Open Payments shows 344 general payments to Dr. Nussbaum from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Medtronic, Inc. paid the most, $5,475.

Dr. Nussbaum graduated from Chicago College of Medicine and Surgery in 1997.